298 related articles for article (PubMed ID: 17197180)
41. Anti-neutrophilic inflammatory secondary metabolites from the traditional Chinese medicine, Tiankuizi.
Lee CL; Hwang TL; Peng CY; Chen CJ; Chang YS; Wu YC
Nat Prod Commun; 2012 Dec; 7(12):1623-6. PubMed ID: 23413568
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of nitric oxide-releasing derivatives of 3-n-butylphthalide as anti-platelet agents.
Li Y; Wang X; Fu R; Yu W; Wang X; Lai Y; Peng S; Zhang Y
Bioorg Med Chem Lett; 2011 Jul; 21(14):4210-4. PubMed ID: 21684163
[TBL] [Abstract][Full Text] [Related]
43. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
[TBL] [Abstract][Full Text] [Related]
44. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
45. Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
Jones M; Inkielewicz I; Medina C; Santos-Martinez MJ; Radomski A; Radomski MW; Lally MN; Moriarty LM; Gaynor J; Carolan CG; Khan D; O'Byrne P; Harmon S; Holland V; Clancy JM; Gilmer JF
J Med Chem; 2009 Nov; 52(21):6588-98. PubMed ID: 19821574
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
48. Benzo[6,7]cyclohepta[1,2-b]pyran derivatives with platelet antiaggregating and other activities.
Bargagna A; Longobardi M; Mariani E; Schenone P; Cenicola ML; Losasso C; Carnevale M; Marmo E
Farmaco; 1991 Mar; 46(3):461-75. PubMed ID: 1892503
[TBL] [Abstract][Full Text] [Related]
49. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target.
Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G
Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory activities of compounds from the twigs of Garcinia hombroniana Pierre on human low-density lipoprotein (LDL) oxidation and platelet aggregation.
Saputri FC; Jantan I
Phytother Res; 2012 Dec; 26(12):1845-50. PubMed ID: 22422639
[TBL] [Abstract][Full Text] [Related]
51. Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
Lazzarato L; Donnola M; Rolando B; Marini E; Cena C; Coruzzi G; Guaita E; Morini G; Fruttero R; Gasco A; Biondi S; Ongini E
J Med Chem; 2008 Mar; 51(6):1894-903. PubMed ID: 18293898
[TBL] [Abstract][Full Text] [Related]
52. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
53. Amides with anti-platelet aggregation activity from Piper taiwanense.
Chen IS; Chen YC; Liao CH
Fitoterapia; 2007 Sep; 78(6):414-9. PubMed ID: 17590283
[TBL] [Abstract][Full Text] [Related]
54. 2H-1-benzopyran derivatives with platelet antiaggregating and other activities.
Longobardi M; Bargagna A; Mariani E; Schenone P; D'Amico M; Filippelli A; Falzarano C; Lampa E
Farmaco; 1993 Aug; 48(8):1121-30. PubMed ID: 8216674
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
[TBL] [Abstract][Full Text] [Related]
56. 2H-pyrano[3,2-d]-1-benzoxepin derivatives with platelet antiaggregating and other activities.
Longobardi M; Bargagna A; Mariani E; Schenone P; Losasso C; Cenicola ML; D'Antonio M; Marmo E
Farmaco; 1991 Mar; 46(3):449-60. PubMed ID: 1892502
[TBL] [Abstract][Full Text] [Related]
57. Novel antiplatelet constituents from formosan moraceous plants.
Lin CN; Lu CM; Lin HC; Fang SC; Shieh BJ; Hsu MF; Wang JP; Ko FN; Teng CM
J Nat Prod; 1996 Sep; 59(9):834-8. PubMed ID: 8864236
[TBL] [Abstract][Full Text] [Related]
58. 5-substituted 4-isoxazolecarboxamides with platelet antiaggregating and other activities.
Fossa P; Menozzi G; Schenone P; Filippelli W; Russo S; Lucarelli C; Marmo E
Farmaco; 1991 Jun; 46(6):789-802. PubMed ID: 1772564
[TBL] [Abstract][Full Text] [Related]
59. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids.
de Candia M; Summo L; Carrieri A; Altomare C; Nardecchia A; Cellamare S; Carotti A
Bioorg Med Chem; 2003 Apr; 11(7):1439-50. PubMed ID: 12628670
[TBL] [Abstract][Full Text] [Related]
60. 2H,5H-[1]benzothiopyrano [4,3-b]pyran derivatives with platelet antiaggregating activity.
Bargagna A; Longobardi M; Mariani E; Schenone P; Losasso C; Esposito G; Falzarano C; Marmo E
Farmaco; 1990 Apr; 45(4):405-13. PubMed ID: 2400515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
